Search

Search Constraints

You searched for: Author/Creator Mollenhauer, Brit

Search Results

1. [P1–237]: DIFFERENTIAL ROLE OF CSF FATTY ACID BINDING PROTEIN 3, α‐SYNUCLEIN AND ALZHEIMER's DISEASE CORE BIOMARKERS IN LEWY BODY DISORDERS AND ALZHEIMER's DEMENTIA. (1st July 2017)

2. [P4–151]: ALPHA‐SYNUCLEIN BIOMARKER ANALYSIS: ANALYTICAL PERFORMANCE AND INTER‐LABORATORY PRECISION USING A NEW COLORIMETRIC ELISA. (1st July 2017)

3. A geroscience approach for Parkinson's disease: Conceptual framework and design of PROPAG-AGEING project. (March 2021)

4. A new CERAD total score with equally weighted z-scores and additional executive and non-amnestic „CERAD-Plus" tests enhances cognitive diagnosis in patients with Parkinson's disease: Evidence from the LANDSCAPE study. (September 2021)

5. A user's guide for α‐synuclein biomarker studies in biological fluids: Perianalytical considerations. Issue 8 (22nd July 2017)

7. Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia. Issue 8 (14th June 2016)

8. Antibody‐based methods for the measurement of α‐synuclein concentration in human cerebrospinal fluid – method comparison and round robin study. Issue 1 (13th November 2018)

9. Apolipoprotein E ε4 does not affect cognitive performance in patients with Parkinson's disease. (August 2016)